Nexfen Growth: ASIC Lists It as an Impersonator of a Licensed Firm
Verdict up front: Nexfen Growth is on ASIC’s Investor Alert List — not merely as an unlicensed operator, but classified as an Imposter, listed as an impersonation of the licensed Australian firm MEX Australia Pty Ltd. Its own website advertises fixed daily returns and a five-tier referral bonus, and names no regulator, licence number or […]